The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Nomograms for Calculating the Number of Patients Needed for a Clinical Trial with Survival as an Endpoint
Abstract
This paper presents nomograms for calculating the sample size for a clinical trial with survival as an endpoint. The nomograms are valid when survival is exponential and patients enter the study uniformly.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Statistical Analysis of Failure Time Data.
Aitkin, M., Kalbfleisch, J. D., & Prentice, R. L. (1981) · Biometrics · doi:10.2307/2530581 · Cited by 9,877
Evaluation of survival data and two new rank order statistics arising in its consideration.
Mantel, N. (1966) · PubMed · Cited by 7,519
Asymptotically Efficient Rank Invariant Test Procedures
Peto, R., & Peto, J. (1972) · Journal of the Royal Statistical Society. Series A (General) · doi:10.2307/2344317 · Cited by 3,393
Mathematical Statistics: Basic Ideas and Selected Topics.
Wachter, K. W., Bickel, P. J., & Doksum, K. A. (1979) · Journal of the American Statistical Association · doi:10.2307/2286373 · Cited by 1,886
Statistical controversies in the design of clinical trials—Some personal views
Brown, B. W. (1980) · Controlled Clinical Trials · doi:10.1016/s0197-2456(80)80004-3 · Cited by 87
Cited by
Douillard, J., Cunningham, D., Roth, A., Navarro, M., James, R., Karasek, P., Jandik, P., Iveson, T., Carmichael, J., Alakl, M., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02034-1 · Cited by 3,256
Rinke, A., Müller, H.-H., Schade-Brittinger, C., Klose, K.-J., Barth, P., Wied, M., Mayer, C., Aminossadati, B., Pape, U.-F., Bläker, M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.8510 · Cited by 2,508
Power and sample size calculations
Dupont, W. D., & Plummer, W. D. (1990) · Controlled Clinical Trials · doi:10.1016/0197-2456(90)90005-m · Cited by 2,092
Adjuvant Capecitabine for Breast Cancer after Preoperative Chemotherapy
Masuda, N., Lee, S.-J., Ohtani, S., Im, Y.-H., Lee, E.-S., Yokota, I., Kuroi, K., Im, S.-A., Park, B.-W., Kim, S.-B., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1612645 · Cited by 1,888
Continuous Positive Airway Pressure for Central Sleep Apnea and Heart Failure
Bradley, T. D., Logan, A. G., Kimoff, R. J., Sériès, F., Morrison, D., Ferguson, K., Belenkie, I., Pfeifer, M., Fleetham, J., Hanly, P., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051001 · Cited by 1,189
Sample-Size Formula for the Proportional-Hazards Regression Model
Schoenfeld, D. A. (1983) · Biometrics · doi:10.2307/2531021 · Cited by 1,096
Self-citationA Randomized Trial of Adjuvant Chemotherapy with Uracil–Tegafur for Adenocarcinoma of the Lung
Kato, H., Ichinose, Y., Ohta, M., Hata, E., Tsubota, N., Tada, H., Watanabe, Y., Wada, H., Tsuboi, M., Hamajima, N., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032792 · Cited by 818
Ford, H. E. R., Marshall, A., Bridgewater, J. A., Janowitz, T., Coxon, F. Y., Wadsley, J., Mansoor, W., Fyfe, D., Madhusudan, S., Middleton, G. W., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70549-7 · Cited by 595
Martineau, A. R., Timms, P. M., Bothamley, G. H., Hanifa, Y., Islam, K., Claxton, A. P., Packe, G. E., Moore-Gillon, J. C., Darmalingam, M., Davidson, R. N., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61889-2 · Cited by 580
Compression stockings to prevent post-thrombotic syndrome: a randomised placebo-controlled trial
Kahn, S. R., Shapiro, S., Wells, P. S., Rodger, M. A., Kovacs, M. J., Anderson, D. R., Tagalakis, V., Houweling, A. H., Ducruet, T., Holcroft, C., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61902-9 · Cited by 524
Singer, J. D., & Willett, J. B. (1991) · Psychological Bulletin · doi:10.1037//0033-2909.110.2.268 · Cited by 414
Lachin, J. M., & Foulkes, M. A. (1986) · Biometrics · doi:10.2307/2531201 · Cited by 400
Kitagawa, R., Katsumata, N., Shibata, T., Kamura, T., Kasamatsu, T., Nakanishi, T., Nishimura, S., Ushijima, K., Takano, M., Satoh, T., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.4391 · Cited by 389
Katai, H., Mizusawa, J., Katayama, H., Takagi, M., Yoshikawa, T., Fukagawa, T., Terashima, M., Misawa, K., Teshima, S., Koeda, K., et al. (2017) · Gastric Cancer · doi:10.1007/s10120-016-0646-9 · Cited by 388
Lorenz, M., Müller, H.-H., Schramm, H., Gassel, H.-J., Rau, H.-G., Ridwelski, K., Hauss, J., Stieger, R., Jauch, K.-W., Bechstein, W. O., et al. (1998) · Annals of Surgery · doi:10.1097/00000658-199812000-00006 · Cited by 356
for the SAKK and the German CML Study Group, Hehlmann, R., Lauseker, M., Saußele, S., Pfirrmann, M., Krause, S., Kolb, H. J., Neubauer, A., Hossfeld, D. K., Nerl, C., et al. (2017) · Leukemia · doi:10.1038/leu.2017.253 · Cited by 341
Katai, H., Mizusawa, J., Katayama, H., Morita, S., Yamada, T., Bando, E., Ito, S., Takagi, M., Takagane, A., Teshima, S., et al. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30332-2 · Cited by 330
Lorenz, M., Müller, H.-H., & for the German Cooperative Group on Liver Metastases (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.2.243 · Cited by 308
Sample size calculations for ordered categorical data
Whitehead, J. (1993) · Statistics in Medicine · doi:10.1002/sim.4780122404 · Cited by 297
Nakamura, K., Kato, K., Igaki, H., Ito, Y., Mizusawa, J., Ando, N., Udagawa, H., Tsubosa, Y., Daiko, H., Hironaka, S., et al. (2013) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyt061 · Cited by 289
Kato, K., Machida, R., Ito, Y., Daiko, H., Ozawa, S., Ogata, T., Hara, H., Kojima, T., Abe, T., Bamba, T., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00745-1 · Cited by 280
A Controlled Trial of an Educational Program to Prevent Low Back Injuries
Daltroy, L. H., Iversen, M. D., Larson, M. G., Lew, R., Wright, E., Ryan, J., Zwerling, C., Fossel, A. H., & Liang, M. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199707313370507 · Cited by 271
Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) Trial
Holmes, D. R., Savage, M., LaBlanche, J.-M., Grip, L., Serruys, P. W., Fitzgerald, P., Fischman, D., Goldberg, S., Brinker, J. A., Zeiher, A. M., et al. (2002) · Circulation · doi:10.1161/01.cir.0000028335.31300.da · Cited by 260
Arnold, R., Rinke, A., Klose, K.-J., Müller, H.-H., Wied, M., Zamzow, K., Schmidt, C., Schade-Brittinger, C., Barth, P., Moll, R., et al. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(05)00481-7 · Cited by 254
on Behalf of the Japan Clinical Oncology Group (JCOG)-Lung Cancer Study Group, Okamoto, H., Watanabe, K., Kunikane, H., Yokoyama, A., Kudoh, S., Asakawa, T., Shibata, T., Kunitoh, H., Tamura, T., et al. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603810 · Cited by 213
“This trial was designed as a superiority trial and the planned sample size was 110 patients in each arm for 80% power to detect a 0.67 hazard ratio for CE to SPE in OS at an alpha of 0.025 (one sided) (Schoenfeld and Richter, 1982).”
InfluentialFisher, B. J., Hu, C., Macdonald, D. R., Lesser, G. J., Coons, S. W., Brachman, D. G., Ryu, S., Werner-Wasik, M., Bahary, J.-P., Liu, J., et al. (2015) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2014.11.012 · Cited by 163
On behalf of the HOMES-HF study investigators, Kotooka, N., Kitakaze, M., Nagashima, K., Asaka, M., Kinugasa, Y., Nochioka, K., Mizuno, A., Nagatomo, D., Mine, D., et al. (2018) · Heart and Vessels · doi:10.1007/s00380-018-1133-5 · Cited by 66
Metadata
- Authors
- Schoenfeld, D. A., & Richter, J. R.
- Venue
- Biometrics
- Publisher
- JSTOR
- Published
- 1982-03
- Volume
- 38
- Issue
- 1
- Pages
- 163
- ISSN
- 0006-341X (ISSN-L)
- OpenAlex
- W1970029232
- Cited by
- 354
- References
- 5
- FWCI
- 1.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.